Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
SEC Accession No. 0000950136-05-006331
Filing Date
2005-10-07
Accepted
2005-10-07 14:42:24
Documents
1
Group Members
APOTEX HOLDINGS INC.SHERFAM INC.SHERMAN DELAWARE, INC.SHERMAN HOLDINGS INC.SHERMCO INC.SHERMFIN INC.THE BERNARD SHERMAN 2000 TRUST

Document Format Files

Seq Description Document Type Size
1 AMENDMENT TO SCHEDULE 13D file001.htm SC 13D/A 43285
  Complete submission text file 0000950136-05-006331.txt   45348
Mailing Address 2 QUAKER RD BOX 2900 POMONA NY 10970-0519
Business Address 2 QUAKER RD BOX 2900 POMONA NY 10970-0519 8453621100
BARR PHARMACEUTICALS INC (Subject) CIK: 0000010081 (see all company filings)

EIN.: 221927534 | State of Incorp.: DE | Fiscal Year End: 0630
Type: SC 13D/A | Act: 34 | File No.: 005-42092 | Film No.: 051129375
SIC: 2834 Pharmaceutical Preparations

Mailing Address HARTMAN & CRAVEN LLP 460 PARK AVENUE NEW YORK NY 10022
Business Address 4167499300
SHERMAN BERNARD C (Filed by) CIK: 0000936837 (see all company filings)

Type: SC 13D/A